GNTA — Genenta Science S.p.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1838716 ·
Last close
$0.60
Market Cap
$14.09M
52W High
$1.04
52W Low
$0.55
ADV30
47,574
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 31,889,310 | 5,527,672 | 10,048,670 |
| Dec 2024 | — | — | — | — | 14,823,993 | 4,581,749 | 2,328,287 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-62,585,347
Inventory
—
Receivables
$1,285,630
ST Investments
$22,621,518
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,603,740 | -6,529,827 | 31,889,310 | 10,048,670 | — | -6,867,959 |
| Dec 2024 | 0 | -9,764,310 | -8,912,495 | 14,823,993 | 2,328,287 | — | -6,240,174 |
| Dec 2023 | 0 | -11,732,942 | -11,645,455 | 22,347,145 | 1,914,888 | — | -11,205,023 |
| Dec 2022 | 0 | -11,043,992 | -8,477,763 | 33,437,860 | 2,299,694 | — | -7,418,236 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.65
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZEOX | Zeo ScientifiX, Inc. | $14.78M | $1.90 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | $12.65M | $4.68 | — |
| PHGE | BiomX Inc. | $16.38M | $1.62 | — |
| INAB | IN8BIO, INC. | $16.64M | $1.69 | — |
| CUBT | Curative Biotechnology Inc | $11.49M | $1.50 | — |
News headlines (Yahoo Finance, 1h cache)
Genenta signs Definitive Agreements with Sophia High Tech
2026-04-23 11:00 · Yahoo
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
2026-03-27 09:00 · Yahoo
Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini
2026-03-24 07:27 · Yahoo
European Equities Traded in the US as American Depositary Receipts Higher Tuesday
2026-03-17 15:18 · Yahoo
Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University
2026-03-13 09:00 · Yahoo
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business
2026-02-28 00:53 · Yahoo
Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform
2026-02-27 09:00 · Yahoo
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator
2026-01-27 08:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Gain Friday
2026-01-02 16:09 · Yahoo
Genenta Science Provides Update on CEO Ownership
2025-12-19 07:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.